Streb, Joanna

• Vol 7, Supp. D (2011) - CASE REPORT
  Całkowita regresja zmian w mózgu u chorej na raka piersi z nadmierną ekspresją HER2 po radioterapii i leczeniu lapatynibem z kapecytabiną
  Details
• Vol 12, No 1 (2016) - REVIEW ARTICLES
  The role of anthracyclines and dose dense therapy in an adjuvant setting, in HER2-positive early breast cancer, in clinical practice
  Abstract  PDF  HTML
• Vol 16, No 2 (2020) - STANOWISKO EKSPERTÓW (EXPERTS' OPINION)
  Systemic treatment of patients with solid tumors during the COVID-19 (SARS-CoV-2) pandemic — comprehensive recommendations of the Polish Society of Clinical Oncology
  Details  PDF
• Ahead of print - ORIGINAL ARTICLES
  Systemic treatment of patients with advanced pancreatic cancer — is there still a place for gemcitabine in the first-line setting? Experience of Polish oncology centers
  Abstract  PDF
• Ahead of print - ORIGINAL ARTICLES
  Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune-inflammation index as clinical predictive and prognostic markers in patients with advanced pancreatic cancer receiving gemcitabine monotherapy
  Abstract  PDF
• Ahead of print - ORIGINAL ARTICLES
  Encorafenib plus cetuximab in patients with BRAFV600E-mutated metastatic colorectal cancer — Polish multicenter experience
  Abstract  PDF